Q9Y468 (LMBL1_HUMAN) Homo sapiens (Human)
Lethal(3)malignant brain tumor-like protein 1 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
20 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of the 3-MBT domain from human L3MBTL1 in complex with H1.5K27me2 at 1.66 angstrom |
Heteromer P16401; | 1×PG4; 1×PEG; | ||||
| Assess | ||||||
| Crystal structure of L3MBTL1 in complex with H4K20Me2 (residues 17-25), orthorhombic form II |
Heteromer P62805; | 1×CL; | ||||
| Assess | ||||||
| Crystal structure of the 3-MBT domain from human L3MBTL1 in complex with p53K382me1 |
Heteromer P04637; | |||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF 3-MBT REPEATS OF LETHAL (3) MALIGNANT BRAIN TUMOR (SELENO-MET) AT 1.85 ANGSTROM | homo-9-mer | 42×SO4; 21×MES; | ||||
| Assess | ||||||
| Crystal Structure of 3-MBT repeats of lethal (3) malignant Brain Tumor (Native-I) at 1.85 angstrom | homo-9-mer | 30×SO4; 18×MES; | ||||
| Assess | ||||||
| Crystal structure of L3MBTL1 in complex with H4K20Me2 (residues 12-30), orthorhombic form I | homo-2-mer | |||||
| Assess | ||||||
| Crystal structure of L3MBTL1 protein | monomer | |||||
| Assess | ||||||
| Crystal structure of the 3-MBT repeats from human L3MBTL1 bound to dimethyl-lysine and in chimera w… | monomer | 1×SO4; 1×MLY; 1×PG4; 1×PEG; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF 3-MBT REPEATS OF LETHAL (3) MALIGNANT BRAIN TUMOR (NATIVE-II) AT 1.55 ANGSTROM | monomer | 4×SO4; 4×MES; | ||||
| Assess | ||||||
| The 3-MBT repeat domain of L3MBTL1 in complex with a methyl-lysine mimic | monomer | 1×UWN; 14×UNX; | ||||
| Assess | ||||||
| Crystal structure of the 3-MBT repeats from human L3MBTL1 bound to dimethyl-lysine | monomer | 2×SO4; 1×MLY; 1×PG4; 1×PGE; | ||||
| Assess | ||||||
| Crystal structure of L3MBTL1 MBT Domain with MBK14970 | monomer | 1×EC7; 8×EDO; 13×UNX; | ||||
| Assess | ||||||
| Crystal structure of L3MBTL1 in complex with H4K20Me2 (residues 17-25), trigonal form | monomer | 3×ACT; | ||||
| Assess | ||||||
| Crystal structure of the 3-MBT repeats from human L3MBTL1 bound to monomethyl-lysine | monomer | 1×MLZ; 1×PEG; | ||||
| Assess | ||||||
| Crystal structure of the 3-MBT repeats from human L3MBTL1 with N358Q point mutation | monomer | 1×PEG; | ||||
| Assess | ||||||
| Crystal structure of the 3-MBT repeats from human L3MBTL1 with N358A point mutation | monomer | 2×PGE; 2×PEG; | ||||
| Assess | ||||||
| Crystal structure of the 3-MBT repeats from human L3MBTL1 with D355A point mutation | monomer | 2×SO4; 2×PGE; 1×PEG; | ||||
| Assess | ||||||
| Crystal structure of the 3-MBT repeats from human L3MBTL1 with D355N point mutation | monomer | 1×PEG; | ||||
| Assess | ||||||
| Crystal structure of L3MBTL1 protein in complex with MES | monomer | 2×SO4; 2×MES; | ||||
| Assess | ||||||
| Crystal structure of L3MBTL1 (MBT repeat) in complex with a nicotinamide antagonist | monomer | 1×P8H; 1×SO4; 2×GOL; | ||||
| Assess | ||||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 1oz2.1.A | monomer | 0.87 | 3×MES; | 100.00 | ||
| Assess | ||||||
| 2jyd.1.A | monomer | 0.55 | 1×ZN; | 61.11 | ||
| Assess | ||||||
8 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 1 | 1oz2.1.A | monomer | 0.88 | 3×MES; | 100.00 | |
| Assess | ||||||
| Isoform 1 | 2jyd.1.A | monomer | 0.55 | 1×ZN; | 61.11 | |
| Assess | ||||||
| Isoform 2 | 1oz2.1.A | monomer | 0.88 | 3×MES; | 100.00 | |
| Assess | ||||||
| Isoform 2 | 2jyd.1.A | monomer | 0.54 | 1×ZN; | 56.41 | |
| Assess | ||||||
| Isoform 3 | 2rjf.2.C | monomer | 0.87 | 100.00 | ||
| Assess | ||||||
| Isoform 3 | 2biv.1.A | monomer | 0.61 | 37.31 | ||
| Assess | ||||||
| Isoform 4 | 1oz2.1.A | monomer | 0.88 | 3×MES; | 100.00 | |
| Assess | ||||||
| Isoform 4 | 4pzn.1.A | monomer | 0.65 | 40.00 | ||
| Assess | ||||||